STATE STREET CORP - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$39,036
-24.2%
119,7410.0%0.00%
Q1 2023$51,489
-59.4%
119,741
-50.0%
0.00%
Q4 2022$126,926
+44.2%
239,482
+100.0%
0.00%
Q3 2022$88,000
-35.8%
119,7410.0%0.00%
Q2 2022$137,000
-44.1%
119,7410.0%0.00%
Q1 2022$245,000
-22.2%
119,741
+9.4%
0.00%
Q4 2021$315,000
-32.1%
109,4380.0%0.00%
Q3 2021$464,000
-19.9%
109,4380.0%0.00%
Q2 2021$579,000
+972.2%
109,438
+843.4%
0.00%
Q1 2021$54,000
-30.8%
11,600
-50.1%
0.00%
Q2 2020$78,000
-95.2%
23,250
-94.5%
0.00%
Q1 2020$1,627,000
-33.3%
424,725
+5.2%
0.00%
Q4 2019$2,438,000
-16.0%
403,691
+5.1%
0.00%
Q3 2019$2,903,000
-39.2%
383,997
+8.9%
0.00%
Q2 2019$4,778,000
+5329.5%
352,652
+2071.8%
0.00%
Q1 2019$88,000
+79.6%
16,238
-0.9%
0.00%
Q4 2018$49,000
-64.2%
16,378
-3.0%
0.00%
Q3 2018$137,000
-22.2%
16,888
-5.9%
0.00%
Q2 2018$176,000
-88.9%
17,951
-90.2%
0.00%
Q1 2018$1,592,000
-24.6%
183,391
+8.7%
0.00%
Q4 2017$2,111,000
+67.9%
168,683
+12.1%
0.00%
Q3 2017$1,257,000
-53.4%
150,419
-5.4%
0.00%
Q2 2017$2,698,000
+657.9%
158,965
+322.5%
0.00%
Q1 2016$356,000
-4.3%
37,629
+1.5%
0.00%
Q4 2015$372,00037,0670.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
King Wealth Management Group 16,000$33,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders